Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries

BackgroundAs cancer payment models transition from fee for service toward payment “bundles” based on episodes of care, a deeper understanding of the costs associated with stage I lung cancer treatment becomes increasingly relevant. To better understand costs in early lung cancer care, we sought to characterize hospital-level variation in Medicare expenditure after lobectomy for stage I non-small cell lung carcinoma.MethodsPatients who were...